HARBOURVEST PARTNERS LLC — 13F Holdings & Portfolio

CIK 1201001 · latest 13F-HR filed 2026-05-15

HARBOURVEST PARTNERS LLC manages $100.9M in 13F-reported U.S. long-equity assets across 5 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are KLAR (65.17%), GENB (21.33%), YMM (7.88%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 1 new position, exited 3, added to 1, and trimmed 3.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$100.9M

Long-equity book

Holdings

5

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+1 / −3 / ↑1 / ↓3

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Century Therapeutics, Inc.$36.7K +127.2%
Show all 1

Top Trims

  • Klarna Group PLC-$79.5M -54.7%
  • Full Truck Alliance Co. Ltd.-$2.3M -22.6%
  • CAMP4 Therapeutics Corp-$2.2M -28.1%
Show all 3

New Positions

  • Generate Biomedicines$21.5M
Show all 1

Exited Positions

  • Rubrik, Inc.$6.9M
  • Epsilon Energy LTD$3.9M
  • Repare Therapeutics, Inc.$31.9K
Show all 3
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Klarna Group PLC KLAR G5279N105 $65.8M 65.17% 5,023,320 SH
2 Generate Biomedicines GENB 370920100 $21.5M 21.33% 1,722,210 SH
3 Full Truck Alliance Co. Ltd. YMM 35969L108 $7.9M 7.88% 957,580 SH
4 CAMP4 Therapeutics Corp CAMP 13463J101 $5.6M 5.56% 1,271,948 SH
5 Century Therapeutics, Inc. IPSC 15673T100 $65.6K 0.06% 29,018 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $100.9M 5 0001193125-26-225130
2025-12-31 2026-02-17 $174.2M 7 0001193125-26-052872
2025-09-30 2025-11-14 $205.1M 9 0001193125-25-281332